134 results
Page 4 of 7
6-K
EX-99
3ouf0
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-1
dma6a5 vy
28 May 19
Current report (foreign)
7:04am
6-K
EX-99
dhp n2fm409urf4
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
r5lpv9zcddmhy
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
dzrg1ejxswyqptses7
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
w0e04d8fk53f8
4 Feb 19
Prospectus supplement for primary offering
5:52pm
6-K
EX-10.2
su0dih
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.3
3p61vg
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
F-3/A
c7ag31ubqo
16 Oct 15
Shelf registration (foreign) (amended)
12:00am
20-F/A
EX-4.39
41fu2 h924rv7p
22 Sep 15
Annual report (foreign) (amended)
12:00am
424B3
EX-1
kaud3n4p94xx 12u
8 Jun 15
Prospectus supplement
12:00am